Literature DB >> 18852343

Friedreich ataxia.

Massimo Pandolfo1.   

Abstract

Friedreich ataxia is an autosomal recessive degenerative disease that primarily affects the nervous system and the heart. It is named after its original description as a "degenerative atrophy of the posterior columns of the spinal cord" by Nicholaus Friedreich, who was a professor of medicine in Heidelberg in the second half of the 19th century. The full extent of the Friedreich ataxia phenotype and its genetic epidemiology could only be appreciated after a direct genetic test became available in 1996. At the same time, the complex pathogenesis of Friedreich ataxia started to be unraveled. Herein, I review our current knowledge of the disease and how it is contributing to the development of therapeutic approaches.

Entities:  

Mesh:

Year:  2008        PMID: 18852343     DOI: 10.1001/archneur.65.10.1296

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  70 in total

1.  A gene expression phenotype in lymphocytes from Friedreich ataxia patients.

Authors:  Giovanni Coppola; Ryan Burnett; Susan Perlman; Revital Versano; Fuying Gao; Heather Plasterer; Myriam Rai; Francesco Saccá; Alessandro Filla; David R Lynch; James R Rusche; Joel M Gottesfeld; Massimo Pandolfo; Daniel H Geschwind
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

Review 2.  [Clinical details and genetics of recessive ataxias].

Authors:  C Zühlke; F Kreuz; K Bürk
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

Review 3.  Developments in RNA splicing and disease.

Authors:  Michael G Poulos; Ranjan Batra; Konstantinos Charizanis; Maurice S Swanson
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

4.  Restless legs and substantia nigra hypoechogenicity are common features in Friedreich's ataxia.

Authors:  Matthis Synofzik; Jana Godau; Tobias Lindig; Ludger Schöls; Daniela Berg
Journal:  Cerebellum       Date:  2011-03       Impact factor: 3.847

5.  Epigenetic therapy for Friedreich ataxia.

Authors:  Elisabetta Soragni; Wenyan Miao; Marco Iudicello; David Jacoby; Stefania De Mercanti; Marinella Clerico; Filomena Longo; Antonio Piga; Sherman Ku; Erica Campau; Jintang Du; Pablo Penalver; Myriam Rai; Joseph C Madara; Kristopher Nazor; Melinda O'Connor; Anton Maximov; Jeanne F Loring; Massimo Pandolfo; Luca Durelli; Joel M Gottesfeld; James R Rusche
Journal:  Ann Neurol       Date:  2014-09-16       Impact factor: 10.422

Review 6.  Epigenetic changes and non-coding expanded repeats.

Authors:  Masayuki Nakamori; Charles Thornton
Journal:  Neurobiol Dis       Date:  2010-02-18       Impact factor: 5.996

7.  White matter changes in patients with friedreich ataxia after treatment with erythropoietin.

Authors:  Karl Egger; Christian Clemm von Hohenberg; Michael F Schocke; Charles R G Guttmann; Demian Wassermann; Marlene C Wigand; Wolfgang Nachbauer; Christian Kremser; Brigitte Sturm; Barbara Scheiber-Mojdehkar; Marek Kubicki; Martha E Shenton; Sylvia Boesch
Journal:  J Neuroimaging       Date:  2013-09-09       Impact factor: 2.486

Review 8.  The neurodegenerative mitochondriopathies.

Authors:  Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

9.  Neuroanatomical correlates of depression in Friedreich's ataxia: a voxel-based morphometry study.

Authors:  Cynthia B da Silva; Clarissa L Yasuda; Anelyssa D'Abreu; Fernando Cendes; Iscia Lopes-Cendes; Marcondes C França
Journal:  Cerebellum       Date:  2013-06       Impact factor: 3.847

10.  Impairment in motor reprogramming in Friedreich ataxia reflecting possible cerebellar dysfunction.

Authors:  Louise A Corben; Martin B Delatycki; John L Bradshaw; Malcolm K Horne; Michael C Fahey; Andrew J Churchyard; Nellie Georgiou-Karistianis
Journal:  J Neurol       Date:  2009-12-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.